Immix Biopharma, Inc. IMMX Cash Cash Equivalents And Short Term Investments
Cash Cash Equivalents And Short Term Investments at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsAndShortTermInvestments.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s cash cash equivalents and short term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s cash cash equivalents and short term investments?
- Immix Biopharma, Inc. (IMMX) reported cash cash equivalents and short term investments of $90.6M in Q1 2026.